Skip to content

13F-HR filed by Nextech Invest Ltd.

Nextech Invest Ltd. filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 13 holding rows worth $594,463,863.

Accession
0001104659-24-089665
Filed
2024-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A holdings report, 13 entries on the cover page, a total value of $594,463,863 stated on the cover page (in dollars after the unit check, H1), rows summing to $594,463,863 with VALUE read as dollars as filed, 13F file number 028-22157. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REVOLUTION MEDICINES INC COM76155X100Stock6,296,740$244,376,479dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK4,055,861$64,853,217dollars as filed
TANGO THERAPEUTICS INC87583X109COM5,533,980$47,481,548dollars as filed
CARGO THERAPEUTICS INC COM14179K101Stock2,642,502$43,389,883dollars as filed
ARVINAS INC04335A105COM1,408,394$37,491,448dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM5,285,714$37,369,998dollars as filed
RELAY THERAPEUTICS INC COM75943R102Stock3,846,409$25,078,587dollars as filed
CULLINAN THERAPEUTICS INC230031106COM1,221,145$21,296,769dollars as filed
Mersana Therapeutics Inc59045L106Common Stock9,526,146$19,147,553dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS952,400$18,095,600dollars as filed
ARS PHARMACEUTICALS INC82835W108COM1,910,029$16,254,347dollars as filed
CONTEXT THERAPEUTICS INC21077P108COM7,419,355$14,875,807dollars as filed
BOUNDLESS BIO INC10170A100COM1,228,069$4,752,627dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-24-089665this filing2024-08-14acceptance time not in the bulk data set